HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Oncology
RCT
Online mindfulness-based cognitive therapy reduces distress in cancer patients over 9-month follow-up.
Cancer Patients Find Lasting Calm With Simple Online Mindfulness
This secondary analysis of a randomized controlled trial evaluated online mindfulness-based cognitive therapy (eMBCT) in 161 cancer patients…
Simple online mindfulness tools offer lasting mental relief for cancer patients.
Apr 19, 2026
Drug Pipeline
Meta-analysis
Network meta-analysis compares prophylactic anticoagulants for central venous catheter-related thrombosis in cancer patients.
Cancer Patients May Avoid Clots With Safer Blood Thinner
This network meta-analysis synthesizes data from 19 clinical studies regarding prophylactic anticoagulation in cancer patients with central …
A new analysis shows one specific blood thinner may protect cancer patients from dangerous clots with fewer side effects.
Frontiers
Apr 19, 2026
Oncology
Sys. Review
Narrative review proposes theoretical applicability of plant non-cancer resistance mechanisms to animal cancer resistance
Plants Never Get Cancer — Could Their Secret Work in Humans Too?
This narrative review synthesizes current literature to propose that fundamental principles of non-cancer resistance (NHR) in plants might a…
Plants never get cancer because of a unique immune logic that scientists now propose could inspire a new way to build cancer-resistant human…
Frontiers
Apr 18, 2026
Oncology
Sys. Review
Narrative review offers novel perspectives on cancer development via RMP ubiquitination targeting.
Cancer Hijacks a Cellular Recycling System — Scientists Are Learning to Fight Back
This narrative review explores the role of targeting RMP ubiquitination in cancer development. The authors synthesize current knowledge to p…
Cancer cells hijack a hidden recycling loop inside healthy cells to grow and spread, but scientists are now mapping this trick to build new …
Frontiers
Apr 18, 2026
Infectious Disease
Sys. Review
Review of Spatial AI combining multi-omics with deep learning for cancer biomarkers
Can AI read the hidden maps of cancer cells to find new ways to fight disease?
This narrative review examines the application of Spatial AI, specifically combining high-resolution spatial multi-omics with deep learning …
Cancer resistance hides in cell neighborhoods, not just individual cells, so new AI maps reveal how tumors organize defenses to block treatm…
Frontiers
Apr 17, 2026
Allergy & Immunology
Sys. Review
Systematic review examines IL-15-based immunotherapy for cancer with manageable toxicity profiles.
New Immune Booster Could Help Cancer Fighters Last Longer
A systematic review evaluated IL-15-based cancer immunotherapy, including recombinant IL-15 and immunocytokines, for cancer treatment. The a…
A new immune booster helps cancer fighters stay active longer, potentially making treatments for solid tumors and CAR-T therapy work far bet…
Frontiers
Apr 16, 2026
Allergy & Immunology
Sys. Review
Systematic review examines immune checkpoint inhibitors, innate immunity, and immune-related adverse events in cancer patients.
A review suggests innate immunity plays a key role in cancer drug side effects.
This systematic review evaluated immune checkpoint inhibitors (ICIs) in patients with cancer, focusing on immune-related adverse events (irA…
Cancer drugs that help fight tumors can also cause serious inflammation, and new research shows the body's first line of defense plays a key…
Frontiers
Apr 16, 2026
Oncology
Meta-analysis
Meta-analysis links elevated DLEU1 expression to shorter survival in cancer patients
High DLEU1 levels in cancer tissue are linked to shorter life and worse tumor spread.
This systematic review and meta-analysis of 938 cancer patients found that elevated DLEU1 expression was associated with shortened overall s…
High levels of a protein called DLEU1 in cancer tissue are linked to shorter life and worse tumor spread across 938 patients.
Frontiers
Apr 16, 2026
Urology
Sys. Review
STING activation targets renal, prostatic, and cancer inflammation in mini-review
The Immune Alarm System in Your Kidneys and Prostate Has a Dark Side
This mini-review discusses STING activation as a potential intervention for renal inflammation, prostatic inflammation, and cancer. The popu…
A molecular alarm in kidneys and prostate that fights infection can get stuck on, driving chronic inflammation, scarring, and cancer risk.
Frontiers
Apr 16, 2026
Oncology
Case-Control
Multi-cancer early detection blood test shows variable sensitivity across cancer stages in case-control study
Blood Test Finds Half of Cancers Before Symptoms Start
This case-control study evaluated a multi-target blood test for early cancer detection across 21 tumor types in 6,352 samples. Overall sensi…
A new blood test detects half of all cancers before symptoms appear, catching aggressive types often missed by current screening tools.
medRxiv
Apr 16, 2026
Oncology
Sys. Review
Narrative review discusses dual role of senescent cells in cancer immunity and emerging therapeutic strategies.
Old Cells Can Fight Cancer
This narrative review examines the complex role of cellular senescence in cancer, specifically focusing on inducing senescence in tumor cell…
Old cells in your body can either kill tumors or help them grow, so new drugs aim to turn these zombie cells into powerful cancer fighters s…
Frontiers
Apr 15, 2026
Oncology
Meta-analysis
Physical activity improves fatigue and muscle strength in pediatric cancer patients based on a meta-analysis of 24 studies.
Does moving more help young cancer patients feel better and fight fatigue?
This systematic review and meta-analysis evaluated physical activity (PA) in children and adolescents with cancer across 24 studies. Signifi…
Getting moving helps young cancer patients feel less fatigued, build stronger muscles, and improve their ability to think clearly and connec…
Frontiers
Apr 14, 2026